Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.
ABA data collection and analysis, now Ensora Data Collection
Prescription digital therapeutic for substance use disorder
Catalyst, built by DataFinch Technologies, is a mobile-first ABA data collection platform for behavior technicians and BCBAs, with discrete trial and skill acquisition data collection, automated graphing, session notes, and a parent portal. DataFinch is now part of Ensora Health (formerly Therapy Brands) and Catalyst is sold today as Ensora Data Collection within the Ensora ABA product line. Ensora's own product page states the platform is HIPAA compliant, lists multi-factor authentication among its features, offers a free 21-day trial with no credit card required, and publishes pricing at $27 per client per month.
reSET is a prescription digital therapeutic that delivers a 12-week course of cognitive behavioral therapy with contingency management through a smartphone app, as an adjunct to outpatient treatment for substance use disorder in adults. It was developed by Pear Therapeutics and in 2017 became the first prescription digital therapeutic authorized by the FDA, through the De Novo pathway. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023 and its assets were sold at auction, but reSET itself is still sold and supported today: PursueCare relaunched it as RESET in October 2024, and XRHealth acquired PursueCare, including RESET and RESET-O, in November 2026.
Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.